164 related articles for article (PubMed ID: 17295769)
1. Effects of thalidomide in experimental models of post-endoscopic retrograde cholangiopancreatography pancreatitis.
Xiong GS; Wu SM; Wang ZH; Mo JZ; Xiao SD
J Gastroenterol Hepatol; 2007 Mar; 22(3):371-6. PubMed ID: 17295769
[TBL] [Abstract][Full Text] [Related]
2. Effects of heparin in experimental models of acute pancreatitis and post-ERCP pancreatitis.
Hackert T; Werner J; Gebhard MM; Klar E
Surgery; 2004 Feb; 135(2):131-8. PubMed ID: 14739847
[TBL] [Abstract][Full Text] [Related]
3. Etanercept, a TNF-alpha binding agent, is ineffective in the prevention of post-ERCP pancreatitis in canines.
Buscaglia JM; Simons BW; Prosser BJ; Ruben DS; Giday SA; Magno P; Clarke JO; Shin EJ; Kalloo AN; Kantsevoy SV; Gabrielson KL; Jagannath SB
JOP; 2008 Jul; 9(4):456-67. PubMed ID: 18648137
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic pancreas stenting followed by needle-knife fistulotomy in patients with sphincter of Oddi dysfunction and difficult cannulation: new method to prevent post-ERCP pancreatitis.
Madácsy L; Kurucsai G; Fejes R; Székely A; Székely I
Dig Endosc; 2009 Jan; 21(1):8-13. PubMed ID: 19691794
[TBL] [Abstract][Full Text] [Related]
5. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent.
Sofuni A; Maguchi H; Itoi T; Katanuma A; Hisai H; Niido T; Toyota M; Fujii T; Harada Y; Takada T
Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1339-46. PubMed ID: 17981247
[TBL] [Abstract][Full Text] [Related]
6. Antisecretory agents for prevention of post-ERCP pancreatitis: rationale for use and clinical results.
Poon RT; Fan ST
JOP; 2003 Jan; 4(1):33-40. PubMed ID: 12555014
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of prophylactic allopurinol use in post-endoscopic retrograde cholangiopancreatography pancreatitis.
Zheng M; Chen Y; Bai J; Xin Y; Pan X; Zhao L
Pancreas; 2008 Oct; 37(3):247-53. PubMed ID: 18815544
[TBL] [Abstract][Full Text] [Related]
8. Intraductal administration of an NK1 receptor antagonist attenuates the inflammatory response to retrograde infusion of radiological contrast in rats: implications for the pathogenesis and prevention of ERCP-induced pancreatitis.
He ZJ; Winston JH; Yusuf TE; Micci MA; Elfert A; Xiao SY; Pasricha PJ
Pancreas; 2003 Jul; 27(1):e13-7. PubMed ID: 12826913
[TBL] [Abstract][Full Text] [Related]
9. The effect of ERCP on circulating pancreatic enzymes and pancreatic protease inhibitors.
Conn M; Goldenberg A; Concepcion L; Mandeli J
Am J Gastroenterol; 1991 Aug; 86(8):1011-4. PubMed ID: 1713406
[TBL] [Abstract][Full Text] [Related]
10. Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.
Zheng M; Chen Y; Yang X; Li J; Zhang Y; Zeng Q
BMC Gastroenterol; 2007 Feb; 7():6. PubMed ID: 17295917
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of recombinant platelet-activating factor acetylhydrolase for reducing the incidence and severity of post-ERCP acute pancreatitis.
Sherman S; Alazmi WM; Lehman GA; Geenen JE; Chuttani R; Kozarek RA; Welch WD; Souza S; Pribble J;
Gastrointest Endosc; 2009 Mar; 69(3 Pt 1):462-72. PubMed ID: 19231487
[TBL] [Abstract][Full Text] [Related]
12. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial.
Lee KT; Lee DH; Yoo BM
Pancreas; 2008 Nov; 37(4):445-8. PubMed ID: 18953260
[TBL] [Abstract][Full Text] [Related]
13. Temporary pancreatic stent to prevent post endoscopic retrograde cholangiopancreatography pancreatitis: a preliminary, single-center, randomized controlled trial.
Tsuchiya T; Itoi T; Sofuni A; Itokawa F; Kurihara T; Ishii K; Tsuji S; Kawai T; Moriyasu F
J Hepatobiliary Pancreat Surg; 2007; 14(3):302-7. PubMed ID: 17520207
[TBL] [Abstract][Full Text] [Related]
14. Thalidomide alleviates acute pancreatitis-associated lung injury via down-regulation of NFκB induced TNF-α.
Lv P; Li HY; Ji SS; Li W; Fan LJ
Pathol Res Pract; 2014 Sep; 210(9):558-64. PubMed ID: 24939146
[TBL] [Abstract][Full Text] [Related]
15. Influence of portal blood on the development of systemic inflammation associated with experimental acute pancreatitis.
Hoyos S; Granell S; Heredia N; Bulbena O; Closa D; Fernández-Cruz L
Surgery; 2005 Feb; 137(2):186-91. PubMed ID: 15674200
[TBL] [Abstract][Full Text] [Related]
16. The value of serum amylase and elastase measurements in the prediction of post-ERCP acute pancreatitis.
Kapetanos D; Kokozidis G; Kinigopoulou P; Xiarchos P; Antonopoulos Z; Progia E; Kitis G
Hepatogastroenterology; 2007 Mar; 54(74):556-60. PubMed ID: 17523321
[TBL] [Abstract][Full Text] [Related]
17. Severity of post-ERCP pancreatitis directly proportional to the invasiveness of endoscopic intervention: a pilot study in a canine model.
Buscaglia JM; Simons BW; Prosser BJ; Ruben DS; Giday SA; Magno P; Clarke JO; Shin EJ; Kalloo AN; Kantsevoy SV; Gabrielson KL; Jagannath SB
Endoscopy; 2008 Jun; 40(6):506-12. PubMed ID: 18478511
[TBL] [Abstract][Full Text] [Related]
18. New frontiers in the pharmacological prevention of post-ERCP pancreatitis: the cytokines.
Demols A; Deviere J
JOP; 2003 Jan; 4(1):49-57. PubMed ID: 12555016
[TBL] [Abstract][Full Text] [Related]
19. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial.
Li ZS; Pan X; Zhang WJ; Gong B; Zhi FC; Guo XG; Li PM; Fan ZN; Sun WS; Shen YZ; Ma SR; Xie WF; Chen MH; Li YQ
Am J Gastroenterol; 2007 Jan; 102(1):46-51. PubMed ID: 17266687
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of recombinant human interleukin-10 in prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in subjects with increased risk.
Sherman S; Cheng CL; Costamagna G; Binmoeller KF; Puespoek A; Aithal GP; Kozarek RA; Chen YK; Van Steenbergen W; Tenner S; Freeman M; Monroe P; Geffner M; Deviere J;
Pancreas; 2009 Apr; 38(3):267-74. PubMed ID: 19214137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
